{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:42:15Z","timestamp":1793911335333,"version":"4.8.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["2020-T1\/IND-19889"],"award-info":[{"award-number":["2020-T1\/IND-19889"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["IF\/00293\/2015"],"award-info":[{"award-number":["IF\/00293\/2015"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["IF\/01159\/2015"],"award-info":[{"award-number":["IF\/01159\/2015"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["SFRH\/BD\/130147\/2017"],"award-info":[{"award-number":["SFRH\/BD\/130147\/2017"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","award":["NORTE-01-0145-FEDER-000039"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000039"]}],"id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","award":["UIDB\/50006\/2020"],"award-info":[{"award-number":["UIDB\/50006\/2020"]}],"id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["734801"],"award-info":[{"award-number":["734801"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.biopha.2022.113525","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T05:17:29Z","timestamp":1661750249000},"page":"113525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Folate receptor-mediated delivery of mitoxantrone-loaded solid lipid nanoparticles to breast cancer cells"],"prefix":"10.1016","volume":"154","author":[{"given":"Andreia","family":"Granja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia T.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salette","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2022.113525_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.biopha.2022.113525_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.biopha.2022.113525_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.breast.2013.10.006","article-title":"Emerging nanotherapeutic strategies in breast cancer","volume":"23","author":"Blanco","year":"2014","journal-title":"Breast"},{"key":"10.1016\/j.biopha.2022.113525_bib4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ctrv.2018.07.004","article-title":"Cancer stem cell in breast cancer therapeutic resistance","volume":"69","author":"Bai","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2022.113525_bib5","first-page":"36","article-title":"Mitoxantrone: an agent with promises for anticancer therapies","volume":"6","author":"Varadwaj","year":"2010","journal-title":"Electron. J. Biol."},{"key":"10.1016\/j.biopha.2022.113525_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0305-7372(83)90020-8","article-title":"Mitoxantrone (novantrone\u2217) as single agent and in combination chemotherapy in the treatment of advanced breast cancer","volume":"10","author":"Smith","year":"1983","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2022.113525_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0277-5379(84)90215-3","article-title":"Mitoxantrone in advanced breast cancer\u2014a phase II study with special attention to cardiotoxicity","volume":"20","author":"Coleman","year":"1984","journal-title":"Eur. J. Cancer Clin. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113525_bib8","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1021\/acs.molpharmaceut.6b01009","article-title":"Mitoxantrone-and folate-TPGS2k conjugate hybrid micellar aggregates to circumvent toxicity and enhance efficiency for breast cancer therapy","volume":"14","author":"Guissi","year":"2017","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2022.113525_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1179\/joc.2005.17.2.215","article-title":"Induction of the ABC-Transporters Mdr1\/P-gp (Abcb1), Mrp1 (Abcc1), and Bcrp (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone","volume":"17","author":"Nieth","year":"2005","journal-title":"J. Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2022.113525_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2022.113525_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2022.113525_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100777","article-title":"Novel nanomedicines to overcome cancer multidrug resistance","volume":"58","author":"Su","year":"2021","journal-title":"Drug Resist. Updates"},{"issue":"9","key":"10.1016\/j.biopha.2022.113525_bib13","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1021\/acs.bioconjchem.9b00456","article-title":"Insights into active targeting of nanoparticles in drug delivery: advances in clinical studies and design considerations for cancer nanomedicine","volume":"30","author":"Pearce","year":"2019","journal-title":"Bioconjugate Chem."},{"issue":"5","key":"10.1016\/j.biopha.2022.113525_bib14","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug delivery in cancer","volume":"14","author":"Cho","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2022.113525_bib15","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers in oral cancer drug delivery","volume":"55","author":"Nasirizadeh","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2022.113525_bib16","series-title":"Lipid Nanoparticles: Production, Characterization and Stability","author":"Shah","year":"2015"},{"issue":"1","key":"10.1016\/j.biopha.2022.113525_bib17","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","volume":"54","author":"Muller","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2022.113525_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application","volume":"5","author":"Naseri","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.biopha.2022.113525_bib19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2022.113525_bib20","article-title":"Utilizing the folate receptor for active targeting of cancer nanotherapeutics","volume":"3","author":"Zwicke","year":"2012","journal-title":"Nano Rev. Exp."},{"issue":"3","key":"10.1016\/j.biopha.2022.113525_bib21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/med.21387","article-title":"Small molecules for active targeting in cancer","volume":"36","author":"Kue","year":"2016","journal-title":"Med. Res. Rev."},{"issue":"4\u20136","key":"10.1016\/j.biopha.2022.113525_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drup.2014.10.002","article-title":"The folate receptor as a rational therapeutic target for personalized cancer treatment","volume":"17","author":"Assaraf","year":"2014","journal-title":"Drug Resist. Updates"},{"issue":"2","key":"10.1016\/j.biopha.2022.113525_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11095-015-1788-x","article-title":"Oxaprozin-loaded lipid nanoparticles towards overcoming NSAIDs side-effects","volume":"33","author":"Lopes-de-Ara\u00fajo","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2022.113525_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121044","article-title":"Mitoxantrone-loaded lipid nanoparticles for breast cancer therapy\u2013quality-by-design approach and efficacy assessment in 2D and 3D in vitro cancer models","author":"Granja","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2022.113525_bib25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/nano10050986","article-title":"Freeze-dried Softisan\u00ae 649-based lipid nanoparticles for enhanced skin delivery of cyclosporine A","volume":"10","author":"Silva","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2022.113525_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120029","article-title":"Targeted nanostructured lipid carriers for doxorubicin oral delivery","volume":"592","author":"Moraes","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2022.113525_bib27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"J. Pharm. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2022.113525_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11020124","article-title":"Nanodrug delivery systems modulate tumor vessels to increase the enhanced permeability and retention effect","volume":"11","author":"Huang","year":"2021","journal-title":"J. Pers. Med."},{"issue":"3","key":"10.1016\/j.biopha.2022.113525_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113525_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2022.113525_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.colsurfb.2011.10.056","article-title":"Physicochemical characterization of engineered nanoparticles under physiological conditions: effect of culture media components and particle surface coating","volume":"91","author":"Fatisson","year":"2012","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.biopha.2022.113525_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0045-6535(00)00605-6","article-title":"Effects of a non-ionic surfactant (Tween-80) on the mineralization, metabolism and uptake of phenanthrene in wheat-solution-lava microcosm","volume":"45","author":"Li","year":"2001","journal-title":"Chemosphere"},{"issue":"3","key":"10.1016\/j.biopha.2022.113525_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2008.05.003","article-title":"Recent progress in tumor pH targeting nanotechnology","volume":"132","author":"Lee","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2022.113525_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.colsurfb.2016.11.042","article-title":"Study of the pH-sensitive mechanism of tumor-targeting liposomes","volume":"151","author":"Fan","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2022.113525_bib35","unstructured":"ISO10993-4, Biological Evaluation of Medical Devices Part 4. Selection of Tests for Interactions with Blood. 2017."},{"key":"10.1016\/j.biopha.2022.113525_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.colsurfb.2013.03.037","article-title":"Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells","volume":"110","author":"Miao","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"6","key":"10.1016\/j.biopha.2022.113525_bib37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3923\/biotech.2011.528.533","article-title":"Cytotoxicity effect of solid lipid nanoparticles on human breast cancer cell lines","volume":"10","author":"Abbasalipourkabir","year":"2011","journal-title":"Biotechnology"},{"key":"10.1016\/j.biopha.2022.113525_bib38","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.2147\/IJN.S145620","article-title":"Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor","volume":"12","author":"Xu","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2022.113525_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bios.2018.05.025","article-title":"Probing the specific binding of folic acid to folate receptor using amino-functionalized mesoporous silica nanoparticles for differentiation of MCF 7 tumoral cells from MCF 10A","volume":"115","author":"Soleymani","year":"2018","journal-title":"Biosens. Bioelectron."},{"issue":"6","key":"10.1016\/j.biopha.2022.113525_bib40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0006-2952(87)90176-6","article-title":"Membrane transport of mitoxantrone by L1210 leukemia cells","volume":"36","author":"Burns","year":"1987","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113525_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bcp.2005.03.032","article-title":"Transport of anthracyclines and mitoxantrone across membranes by a flip-flop mechanism","volume":"70","author":"Regev","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"48","key":"10.1016\/j.biopha.2022.113525_bib42","doi-asserted-by":"crossref","first-page":"26880","DOI":"10.1021\/acsami.5b09483","article-title":"Enhancing cellular uptake and doxorubicin delivery of mesoporous silica nanoparticles via surface functionalization: effects of serum","volume":"7","author":"Shahabi","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.biopha.2022.113525_bib43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2004.02.003","article-title":"Folate receptor targeted biodegradable polymeric doxorubicin micelles","volume":"96","author":"Yoo","year":"2004","journal-title":"J. Control. Release"},{"issue":"42","key":"10.1016\/j.biopha.2022.113525_bib44","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1038\/sj.onc.1207936","article-title":"Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells","volume":"23","author":"Kluza","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2022.113525_bib45","first-page":"2101","article-title":"Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery","volume":"10","author":"Zhang","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.biopha.2022.113525_bib46","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biomaterials.2009.09.090","article-title":"Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells","volume":"31","author":"Setua","year":"2010","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.biopha.2022.113525_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/nano7110349","article-title":"Endocytosis of corn oil-caseinate emulsions in vitro: impacts of droplet sizes","volume":"7","author":"Fan","year":"2017","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2022.113525_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/NSA.S290867","article-title":"Uptake and intracellular trafficking studies of multiple dye-doped core-shell silica nanoparticles in lymphoid and myeloid cells","volume":"14","author":"Sola","year":"2021","journal-title":"Nanotechnol. Sci. Appl."},{"issue":"1","key":"10.1016\/j.biopha.2022.113525_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-016-0241-6","article-title":"Intracellular trafficking and cellular uptake mechanism of PHBV nanoparticles for targeted delivery in epithelial cell lines","volume":"15","author":"Pe\u00f1aloza","year":"2017","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113525_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/pr.58.1.8","article-title":"Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery","volume":"58","author":"Khalil","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2022.113525_bib51","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle\u2013mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"1765","key":"10.1016\/j.biopha.2022.113525_bib52","doi-asserted-by":"crossref","first-page":"20180153","DOI":"10.1098\/rstb.2018.0153","article-title":"The pervasiveness of macropinocytosis in oncological malignancies","volume":"374","author":"Commisso","year":"2019","journal-title":"Philos. Trans. R. Soc. B"},{"key":"10.1016\/j.biopha.2022.113525_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdev.2021.203713","article-title":"Macropinocytosis: biology and mechanisms","author":"Kay","year":"2021","journal-title":"Cells Dev."},{"issue":"10","key":"10.1016\/j.biopha.2022.113525_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205765","article-title":"Redox proteomic insights into involvement of clathrin-mediated endocytosis in silver nanoparticles toxicity to Mytilus galloprovincialis","volume":"13","author":"Bouallegui","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2022.113525_bib55","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/jphp.12134","article-title":"Size-dependent internalisation of folate-decorated nanoparticles via the pathways of clathrin and caveolae-mediated endocytosis in ARPE-19 cells","volume":"66","author":"Suen","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113525_bib56","first-page":"1","article-title":"Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells","volume":"13","author":"Barar","year":"2015","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113525_bib57","doi-asserted-by":"crossref","first-page":"13952","DOI":"10.1021\/acsomega.8b01619","article-title":"Folic acid-conjugated cellulose nanocrystals show high folate-receptor binding affinity and uptake by KB and breast cancer cells","volume":"3","author":"Bittleman","year":"2018","journal-title":"ACS Omega"},{"issue":"17","key":"10.1016\/j.biopha.2022.113525_bib58","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers\u2019 entry into the cell: relevance to drug delivery","volume":"66","author":"Hillaireau","year":"2009","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222009143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222009143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:45:55Z","timestamp":1791661555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222009143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":58,"alternative-id":["S0753332222009143"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113525","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folate receptor-mediated delivery of mitoxantrone-loaded solid lipid nanoparticles to breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113525"}}